Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

The Molecular Basis for Remyelination Failure in Multiple Sclerosis.

Gruchot J, Weyers V, Göttle P, Förster M, Hartung HP, Küry P, Kremer D.

Cells. 2019 Aug 3;8(8). pii: E825. doi: 10.3390/cells8080825. Review.

2.

pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis.

Kremer D, Gruchot J, Weyers V, Oldemeier L, Göttle P, Healy L, Ho Jang J, Kang T Xu Y, Volsko C, Dutta R, Trapp BD, Perron H, Hartung HP, Küry P.

Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15216-15225. doi: 10.1073/pnas.1901283116. Epub 2019 Jun 18.

PMID:
31213545
3.

Regulation of sirtuin expression in autoimmune neuroinflammation: Induction of SIRT1 in oligodendrocyte progenitor cells.

Prozorovski T, Ingwersen J, Lukas D, Göttle P, Koop B, Graf J, Schneider R, Franke K, Schumacher S, Britsch S, Hartung HP, Küry P, Berndt C, Aktas O.

Neurosci Lett. 2019 Jun 21;704:116-125. doi: 10.1016/j.neulet.2019.04.007. Epub 2019 Apr 4.

PMID:
30953735
4.

Remyelination in multiple sclerosis: from concept to clinical trials.

Kremer D, Göttle P, Flores-Rivera J, Hartung HP, Küry P.

Curr Opin Neurol. 2019 Jun;32(3):378-384. doi: 10.1097/WCO.0000000000000692.

PMID:
30865009
5.

Sildenafil Inhibits Myelin Expression and Myelination of Oligodendroglial Precursor Cells.

Muñoz-Esquivel J, Göttle P, Aguirre-Cruz L, Flores-Rivera J, Corona T, Reyes-Terán G, Küry P, Torres KJ.

ASN Neuro. 2019 Jan-Dec;11:1759091419832444. doi: 10.1177/1759091419832444.

6.

A gene regulatory architecture that controls region-independent dynamics of oligodendrocyte differentiation.

Cantone M, Küspert M, Reiprich S, Lai X, Eberhardt M, Göttle P, Beyer F, Azim K, Küry P, Wegner M, Vera J.

Glia. 2019 May;67(5):825-843. doi: 10.1002/glia.23569. Epub 2019 Feb 7. Review.

PMID:
30730593
7.

Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelination.

Göttle P, Förster M, Gruchot J, Kremer D, Hartung HP, Perron H, Küry P.

Glia. 2019 Jan;67(1):160-170. doi: 10.1002/glia.23535. Epub 2018 Nov 14.

PMID:
30430656
8.

Drug repurposing for neuroregeneration in multiple sclerosis.

Küry P, Kremer D, Göttle P.

Neural Regen Res. 2018 Aug;13(8):1366-1367. doi: 10.4103/1673-5374.235242. No abstract available.

9.

Teriflunomide promotes oligodendroglial differentiation and myelination.

Göttle P, Manousi A, Kremer D, Reiche L, Hartung HP, Küry P.

J Neuroinflammation. 2018 Mar 13;15(1):76. doi: 10.1186/s12974-018-1110-z.

10.

Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: "Second International Workshop on Human Endogenous Retroviruses and Disease", Washington DC, March 13th and 14th 2017.

Kremer D, Glanzman R, Traboulsee A, Nath A, Groc L, Horwitz M, Göttle P, Perron H, Gold J, Hartung HP, Küry P.

Mult Scler Relat Disord. 2017 Jul;15:18-23. doi: 10.1016/j.msard.2017.05.001. Epub 2017 May 1.

PMID:
28641767
11.

Pushing Forward: Remyelination as the New Frontier in CNS Diseases.

Kremer D, Göttle P, Hartung HP, Küry P.

Trends Neurosci. 2016 Apr;39(4):246-263. doi: 10.1016/j.tins.2016.02.004. Epub 2016 Mar 7. Review.

PMID:
26964504
12.

CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation.

Kremer D, Cui QL, Göttle P, Kuhlmann T, Hartung HP, Antel J, Küry P.

PLoS One. 2016 Jan 7;11(1):e0146503. doi: 10.1371/journal.pone.0146503. eCollection 2016.

13.

Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?

Göttle P, Küry P.

Int J Mol Sci. 2015 Jul 3;16(7):15057-85. doi: 10.3390/ijms160715057. Review.

14.

Oligodendroglial maturation is dependent on intracellular protein shuttling.

Göttle P, Sabo JK, Heinen A, Venables G, Torres K, Tzekova N, Parras CM, Kremer D, Hartung HP, Cate HS, Küry P.

J Neurosci. 2015 Jan 21;35(3):906-19. doi: 10.1523/JNEUROSCI.1423-14.2015.

15.

The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.

Kremer D, Förster M, Schichel T, Göttle P, Hartung HP, Perron H, Küry P.

Mult Scler. 2015 Aug;21(9):1200-3. doi: 10.1177/1352458514560926. Epub 2014 Dec 5.

PMID:
25480862
16.

Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation.

Jadasz JJ, Kremer D, Göttle P, Tzekova N, Domke J, Rivera FJ, Adjaye J, Hartung HP, Aigner L, Küry P.

PLoS One. 2013 Aug 12;8(8):e71814. doi: 10.1371/journal.pone.0071814. eCollection 2013.

17.

Vinpocetine inhibits oligodendroglial precursor cell differentiation.

Torres KJ, Göttle P, Kremer D, Rivera JF, Aguirre-Cruz L, Corona T, Hartung HP, Küry P.

Cell Physiol Biochem. 2012;30(3):711-22. doi: 10.1159/000341451. Epub 2012 Aug 1.

18.

Activation of CXCR7 receptor promotes oligodendroglial cell maturation.

Göttle P, Kremer D, Jander S, Odemis V, Engele J, Hartung HP, Küry P.

Ann Neurol. 2010 Dec;68(6):915-24. doi: 10.1002/ana.22214.

PMID:
21154415
19.

p57kip2 is dynamically regulated in experimental autoimmune encephalomyelitis and interferes with oligodendroglial maturation.

Kremer D, Heinen A, Jadasz J, Göttle P, Zimmermann K, Zickler P, Jander S, Hartung HP, Küry P.

Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9087-92. doi: 10.1073/pnas.0900204106. Epub 2009 May 19.

20.

The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination.

Heinen A, Kremer D, Göttle P, Kruse F, Hasse B, Lehmann H, Hartung HP, Küry P.

Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8748-53. doi: 10.1073/pnas.0802659105. Epub 2008 Jun 11.

Supplemental Content

Loading ...
Support Center